Page 5 - Seth Lederman News Today

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joined Steve Darling from Proactive to share important news about the companys drug development...

Let’s take a closer look at how to get started in a franchise, even if you are not independently wealthy.

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Dr. Seth Lederman joined Steve Darling from Proactive to announced that Tonix Pharmaceuticals has initiated a Phase...

Topline Results from Four CNS Clinical Trials Expected in the Third and Fourth Quarters of 2023Fibromyalgia Topline Results Expected in the Fourth...

CHATHAM - Tonix Pharmaceuticals Holding Corp. , a biopharmaceutical company, today announced data supporting the memory- and cognition-enhancing effects of two Tonix drug candidates, TNX-601 ER and...

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joins Natalie Stoberman from the Proactive studios to discuss the acquisition of two migraine products...

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joins Natalie Stoberman from the Proactive newsroom to discuss the recent publication of the companys...

Zembrace® SymTouch® (sumatriptan injection) and Tosymra® (sumatriptan nasal spray) are Indicated for the Treatment of Acute Migraine in Adults Strategic Acquisition Helps Build Tonix's Commercial

Mediated recycling • Marketed albumin fusions and conjugates ‒ Levemir ‒ Eperzan / Tanzeum ‒ Victoza ‒ Abraxane ... | June 13, 2023

<iframe src=https://www.youtube.com/embed/1AycYWstVlA></iframe>Tonix Pharmaceuticals CEO Seth Lederman joins Natalie Stoberman from the Proactive studio to discuss the latest results from... | May 31, 2023